Navigation Links
ADVENTRX Announces Establishment of Regulatory Advisory Board
Date:4/9/2012

ted in approvals.

Prior to serving as an independent consultant, Dr. Hepburn served in a number of senior roles, most recently as Senior Vice President, Drug Development, at Santarus, Inc., a specialty biopharmaceutical company in San Diego, focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. At Santarus, Dr. Hepburn was responsible for the establishment of the team responsible for drug development, clinical research and regulatory affairs, which led to the approval of the Zegerid products. Prior to joining Santarus, she served in a variety of senior roles, including Vice President of Clinical Development at La Jolla Pharmaceutical Company, Director of Immunology Clinical Research and head of the infliximab development team at Centocor, Inc., and Head of Inflammation, Bone and Allergy Clinical Research, Executive Director of Anti-inflammatory Research and Director of Regulatory Affairs at Novartis.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on developing proprietary product candidates.  The Company's lead product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has potential application in treating a wide range of diseases and conditions, such as complications arising from sickle cell disease.  We also are developing ANX-514, a novel, detergent-free formulation of the chemotherapy drug docetaxel.  More information can be found on the Company's web site at www.adventrx.com.

Forward Looking Statements
ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are n
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. ADVENTRX Announces Appointment of Senior Vice President, Commercial
2. ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
3. ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
4. ADVENTRX Pharmaceuticals Announces Financing
5. ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
6. ADVENTRX Pharmaceuticals Announces Closing of Financing
7. ADVENTRX Pharmaceuticals Announces Financing
8. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
9. ADVENTRX Announces Further Cost-Cutting Measures
10. ADVENTRX Provides Update on Strategic Transaction Process
11. ADVENTRX Announces Further Cost-Cutting Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: ... and Chief Executive Officer, will present live at ... May 7, 2015     TIME:  11:30 am ET/8:30 am ... the red "register/ watch presentations" button ... where investors are invited to ask the company ...
(Date:5/5/2015)... Washington, and WASHINGTON, D.C., USA (PRWEB) May 05, 2015 ... on U.S. export regulations covering a wide range of ... industry say are hampering global competitiveness of U.S. industry. ... host a webinar on 12 May on ... XII, which governs the commodities covered by International Traffic ...
(Date:5/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5gjj3/clinical ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services ... Global Version" report to their offering. ... of molecular diagnostics and pharmacogenics hold the promise ... that is moving out of the national and ...
(Date:5/5/2015)... , May 5, 2015 CytomX, a ... cancer, today announced that Sean McCarthy , D. ... Suisse Antibody Day in New York ... Dr. McCarthy will present an overview of CytomX,s Probody ... drug conjugate programs. About CytomX Therapeutics ...
Breaking Biology Technology:ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... ... Prostate Surgery, SAN DIEGO, Nov. ... InnerCool Therapies, Inc., today,announced that it has developed a pelvic cooling ... surgery,for prostate cancer (radical prostatectomy). The new technology is being,applied in ...
... Nov. 11 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, Inc. (OTC ... the leading plasma-based pharmaceutical companies in the,People,s Republic ... host a,conference call at 10:00 a.m. EST on ... 2008 results., Hosting the call will be ...
... Care Coverage Gap, WASHINGTON, Nov. 11, 2008 ... the recent political campaigns is often most,prevalent in the ... government,recently took steps to alleviate the problem of critical ... problem that is being exacerbated by,growing physician and nurse ...
Cached Biology Technology:Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 2Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 3Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 4Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 5Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 6Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 7Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries 8China Biologic Products Announces Third Quarter 2008 Results Conference Call 2USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities 2USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities 3
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
(Date:4/13/2015)... -- higi, a leading cloud-based consumer engagement platform that provides ... their communities around health and wellness, announced today the ... ... convenient vehicle to receive validated health information from consumers. ... API will allow higi,s trusted partners, on a user ...
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... and cell biology at the University of Nevada School of ... the National Institute of Health to study the control of ... Keef,s second major NIH RO1 grant in the last 10 ... Approximately five percent of the general community and 15 percent ...
... as a possible culprit in the long-standing mystery of ... region has higher levels of ozone (one of ... The report, which explains how fermented cattle feed works ... Environmental Science & Technology , a semi-monthly journal. ...
... largest ever trial of fish oil supplements has found no ... people. The OPAL study investigated the effects of ... year period on the cognitive function of participants aged 70-80 ... rising and it is estimated that by 2040, more than ...
Cached Biology News:University of Nevada School of Medicine physiology professor earns $1.2 million grant over four years to study motility of internal anal sphincter muscle 2Fish oil supplements provide no benefit to brain power 2
... three Adept CE 4100 high pressure dual ... in one microlitre increaments. The ground ... added flexibility. The WaveQuest provides ... detection and provides superior stability . ...
... Analysis of large numbers of samples may be ... requires minimum operator attention. System control and ... interface CE 4900. The elegant, powerful and ... XP and Windows 98 and 2000., The supplied ...
...
capacity 250 mL...
Biology Products: